<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-60336</identifier>
<setSpec>0212-3568</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pharmacological breakthrough for the treatment of tobacco smoking: vareniclin; a new disposable molecule</dc:title>
<dc:description xml:lang="en">Vareniclin, partially agonist of the nicotinic receptors, is added to the therapies collection of drugs for the front line in the current days, useful when the stop smoking aid is sought. It is a well tolerated drug, sure and with efficiency well proved, just with few secondary effects (AU)</dc:description>
<dc:creator>Granda Orive, J. I. de</dc:creator>
<dc:creator>Gutiérrez Jiménez, T</dc:creator>
<dc:creator>Martínez Albiach, J. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La vareniclina, agonista parcial de los receptores nicotínicos, se añade en el momento actual al arsenal terapéutico de primera línea utilizable para ayudar a dejar de fumar. Se trata de un fármaco bien tolerado, seguro y de eficacia probada con escasos efectos secundarios (AU)</dc:description>
<dc:source>Med. mil;62(4): 213-214, oct.-dic. 2006.</dc:source>
<dc:identifier>ibc-60336</dc:identifier>
<dc:title xml:lang="es">Avances en el tratamiento farmacológico del tabaquismo: vareniclina, una nueva molécula disponible</dc:title>
<dc:subject>^d32112^s22078</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d33882</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d23925^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>200612</dc:date>
</metadata>
</record>
</ibecs-document>
